Professor Julie Bines leads the Enteric Diseases Group at Murdoch Childrens Research Institute and is Professor of Paediatrics at University of Melbourne and a Paediatric Gastroenterologist, Royal Children’s Hospital Melbourne.  Building on the discovery of rotavirus in Melbourne by Professors Ruth Bishop and Ian Holmes in 1973, Professor Bines and the MCRI team have led the development of the human neonatal rotavirus vaccine (RV3-BB vaccine) aimed at preventing rotavirus disease from birth in infants worldwide. This work has included vaccine development, clinical vaccine trials in Australia, New Zealand, Indonesia and Malawi, commercialisation and technology transfer to emerging country vaccine manufacturers, cost-effectiveness analysis and modelling impact. RV3-BB vaccine is expected to be licensed and implemented into the Indonesian routine infant immunisation schedule in 2026. Professor Bines is Director of the WHO Collaborative Centre for Child Health and WHO Rotavirus Regional Reference Laboratory for the Western Pacific Region. Her research also includes understanding barriers to the effectiveness of oral vaccines in high child mortality regions and wastewater surveillance in low- and middle-income countries for typhoid, SARS-CoV-2 and to prepare for future pandemics.